PUNE, India, July 4, 2016 /PRNewswire/ --
Reports on Human Biobanking Market for Applications, Technologies, Equipmentand Ownership are available at RnRMarketResearch.com. These reports review the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic
The Reports are titled:
Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020
Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020
Human Biobanking Equipment - Global Trends, Estimates and Forecasts, 2014-2020
Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020
The Human Biobanking Applications - Global Trends, Estimates and Forecasts, 2014-2020 report says Human Biobanking market is expected to reach US$37.1 billion 2020 primarily supported by application; Stem Cells, Blood and Blood Products, Research and Pharmaceuticals…etc. Among the applications, Advance Application is the fastest growing market with a CAGR of 9.65%. Organs and Research application in human banking together accounts approximately for 24% of the market share. Stem Cells, Blood and Blood Products, Research market with a positive growth rate during the period. Human Biobanking Industry is playing an increasing role in development of therapies and diagnosis of diseases with well-maintained researchers and institutions. Complete report available at http://www.rnrmarketresearch.com/biobanking-applications-a-global-market-watch-2009-2015-market-report.html.
The Human Biobanking Technologies - Global Trends, Estimates and Forecasts, 2014-2020 says Globally, Radio Frequency Identification & Tagging and Dry-State Storing together account for approximately 55% of the market share expected to support the Human Biobanking Technologies industry. Geographical analysis shows that the highest Compounded Annual Growth Rate (CAGR) of 10.14% is anticipated from Asia-Pacific region during the analysis period 2014-2020. North America and Europe together account for more than 50% of the global market share by end of 2020 respectively. Complete report available at http://www.rnrmarketresearch.com/biobanking-technologies-a-global-market-watch-2009-2015-market-report.html.
The Human Biobanking Equipment - Global Trends, Estimates and Forecasts, 2014-2020 says Primarily Supported by segments type; Bio-Freezer and Bio-Refrigerators the Human Biobanking Equipment is the fastest growing market with a CAGR of 8.85%, by the support of emerging countries across world. Biobanking Media is projected to reach US$1.6 billion by 2018. Human Biobanking industry had drawn the attention towards biotechnology and life and environment sciences. Geographical analysis for Human Biobanking Equipments shows the highest Compounded Annual Growth Rate (CAGR) of 10.09% is foreseen from Asia-Pacific region during the analysis period 2014-2020. Europe is not way behind with a CAGR of 9.34% followed by North America at 8.44%. Complete report available at http://www.rnrmarketresearch.com/biobanking-equipments-a-global-market-watch-2009-2015-market-report.html.
And the Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020 says Primarily supported by ownership types; Private Biobanks and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to witness a value of US$37.1 billion by 2020. Geographical analysis for Private Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from Asia-Pacific region during the analysis period 2014-2020. North America is not way behind with a CAGR of 9.95% followed by Europe at 9.56% respectively. Complete report available at http://www.rnrmarketresearch.com/biobanking-ownership-a-global-market-watch-2009-2015-market-report.html.
More than 1270 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
List of Key Companies
North America: Vericel Corporation, Acorda Therapeutics, Inc., Alpha Cord, Inc., Affymetrix, Inc., Cellerant Therapeutics, Inc., Cryo-Cell International, Inc., Mesoblast, Inc., Atgc Labs, Autogen, Inc., Barber Nichols, Beckman Coulter, Inc., Biocision, U.S. Stem Cell, Inc., Biolife Solutions, Inc., Biological Specimen Inventory System, Steelgate, Inc., Thermo Fisher Scientific, Inc., Steelgate, Inc. Wheaton Science Products, Inc. and more.
Europe: Panasonic Biomedical Sales Europe B.V, Epistem Ltd., Aqix, B & C Group, Bbmri, Lifegene, Biobank Ireland Trust, Biokryo Gmbh, Biorep Srl P.Iva, Biostorage Technologies, Inc. Cryo-Save, Ag, Decode Genetics, Ge Healthcare Life Sciences, Sanofi Aventis, Tecan , UK Stem Cell Bank and more.
Asia-Pacific: Cole Parmer Instrument, Co., Cordlife Pte., Ltd., Cryocord Sdn.Bhd., Cryologic Pty. Ltd., Genesearch, Ocimum Biosolutions, China Cord Blood Corporation and more.
Rest of World: Babycell Egypt and Gamida Cell Ltd.
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune - 411013 Maharashtra, India. Tel: +1-888-391-5441 firstname.lastname@example.org
SOURCE RnR Market Research
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All